AtriCure (ATRC) Tops Q2 EPS by 37c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 --0%
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.20), $0.37 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $35.95 million.
2020 Financial Guidance
As previously reported, AtriCure is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
